CL
NYSE · Consumer Defensive · Household & Personal Products · US
Research · Oct 19, 2026
[CL] Colgate-Palmolive: Q3 2026 Earnings Preview on North America Volume and Gross Margin
Colgate-Palmolive grew Q2 2026 net sales 4.9% to $5.36 billion as gross margin rose 140 bps to 61.5%; Q3 tests whether North American volume, down 3.9%, recovers.
Research · Sep 3, 2026
[CL] Colgate-Palmolive Thesis 2026: New Strategy Launches Into Cocoa and Tariff Headwinds
Colgate-Palmolive FY25 (Dec 31, 2025) at $20.38B revenue (+1%). NI $2.13B; EPS $2.63 (-25% on commodity + FX + tariff). FCF $3.63B (+2%). Q4 organic +1.5% across 4 categories. Completed 2025 strategy ($5B incremental sales); pivoted to 2030 strategy. FY26 guide: wide range scenario-based on category growth. Hill's Pet Nutrition continued growth.
Research · Apr 27, 2026
PG Q3 Beats: Sales +7%, Tariff Headwind Cleared
Procter & Gamble's fiscal Q3 results met Wall Street expectations, clearing tariff and margin fears that drove the March selloff. The stock is positioned for a 1-2% tactical move as the downside case is removed, but muted peer response signals limited sector read-through. The trade is a 30-day long in PG, fading if Q4 fails to show margin expansion or if broader market volatility exceeds 5%.